All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...
(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year ...
Dec. 16, 2024 — Scientists have developed a new blood test that could screen cancer patients to help ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their ...
Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML ...
The 37-year-old was fined more than one million euros (£930,000) by Italy's anti-trust authority in December 2023 for claiming that the sales would raise money to help children with bone cancer.
Ear cancer is when abnormal cells in the ear start to grow and divide in an uncontrolled way. Most of these cancers start in the skin of the outer ear. Cancers that develop inside the ear, known as ...
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...
14/L trial (NCT00822393), which enrolled 570 patients aged 18-70 years who had AML or MDS. The patients were randomly assigned to receive treosulfan (n=280) or busulfan (n=290), each given along ...
The deadliest type of blood cancer is generally considered to be acute myeloid leukemia (AML). AML has a survival rate of 31.7% overall, though children and adolescents under the age of 15 tend to do ...
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
A ketogenic diet may have health benefits for the treatment or prevention of cancer. But research is mixed, and it can have downsides for people receiving ongoing cancer treatment. Cancer is most ...